Intra-Cellular Therapies Shares Are Trading Lower After the Company Priced a $500 Million Offering
在该公司定价了5亿美元的发行后,细胞内疗法的股价走低
Intra-Cellular Therapies Shares Are Trading Lower After the Company Priced a $500 Million Offering
在该公司定价了5亿美元的发行后,细胞内疗法的股价走低
使用浏览器的分享功能,分享给你的好友吧